Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS - associated neurological disorders
- 1 January 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (1) , 258-263
- https://doi.org/10.1021/jm00163a043
Abstract
Oxgen-sulfur exchange at the C-4 carbonyl of several modified pyrimidine nucleosides, including 3''-azido-3''-deoxythymidine (AZT), is described in an effort to enhance the lipophilicity and, thereby, the delivery to the central nervous system of the sulfur analogues without compromising the anti-HIV activities of the parental structures. Preparation of 3''-azido-3''-deoxy-4-thiothymidine (3) proceeded from 4-thiothymidine (1) and utilized the same methodology developed for the initial synthesis of AZT. Thiation of 2''-3''-didehydro-3''-deoxythmidine (4a) and 2'',3''-didehydro-2'',3''-dideoxyuridine (4c) was carried out with Lawesson''s reagent on the corresponding 5''-O-benzoate esters, 4b and 4d, to give 5a and 5c, respectively. The latter, on alkaline hydrolysis, gave 2'',3''-didehydro-3''-deoxy-4-thiothymidine (5b) and 2'',3''-didehydro-2'',3''-dideoxyuridine (5d), respectively. The same series of reactions were applied to the 5''-O-benzoate esters of 2'',3''-dideoxyuridine (6a) and 3''-deoxythymidine (6b) to give 2'',3-dideoxy-4-thiouridine (7d) and 3''-deoxy-4-thiothymidine (7b), respectively. Characterization of the saturated and unsaturated thionucleoside included mass spectrometric studies. Under electron impact conditions, the thiated analogues gave more intense parent ions than the corresponding oxygen precursors. The lipophilicity of thymidine and the 3''-deoxythymidine derivatives are enhanced significantly, as indicated, by increases in corresponding P values (1-octanol-0.1 M sodium phosphate) upon replacement of the 4-carbonyl oxygens by sulfur. Compounds 5b, 5d, 7b, and 7d were evaluated for their effects on HIV-induced cytopathogenicity of MT-2 and CEM cells. Only 5b and 7b were moderately active in protecting both cell lines against the cytolytic effect of HIV. The inhibitory effects of analogues 5b, 5d, 7b, and 7d on thymidine phosphorylation by rabbit thymus thymidine kinase were evaluated. Only 3 showed moderate affinity (Ki = 54 .mu.M) for the enzyme. The generally weak anti-HIV activities of the remaining thio analogues are consistent with correspondingly low susceptibilities to thymidine kinase phosphorylation as estimated from the respective Ki values of the synthetic nucleosides. However, the phosphorylation of the 5''-monophosphate derivatives to their respective 5''-triphosphates must also be considered in connective with the weak in vitro anti-HIV effects of these thiated compounds.This publication has 13 references indexed in Scilit:
- The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell speciesBiochemical Pharmacology, 1988
- THE DISPOSITION AND METABOLISM OF 2',3'-DIDEOXYCYTIDINE, AN INVITRO INHIBITOR OF HUMAN T-LYMPHOTROPHIC VIRUS TYPE-III INFECTIVITY, IN MICE AND MONKEYS1987
- THE ANTI-HTLV-III (ANTI-HIV) AND CYTOTOXIC ACTIVITY OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYRIBONUCLEOSIDES - A COMPARISON WITH THEIR PARENTAL 2',3'-DIDEOXYRIBONUCLEOSIDES1987
- 3′-azido-3′-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.Journal of Biological Chemistry, 1987
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986
- The AIDS dementia complex: I. Clinical featuresAnnals of Neurology, 1986
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986